Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Medicamen Biotech Ltd.

  • NSE: MEDICAMEQ

  • BSE: 531146

  • Q
  • V
  • T
  • Expensive Performer
60.25/100

Quality Score

High Financial Strength
16.67/100

Valuation Score

Expensive Valuation
44.19/100

Technical Score

Technically Neutral
Broker Average Rating

0.00

Broker Average Rating

MFI

54.97

MFI is mid-range

50Day SMA Rs

263.27 Rs

Price above SMA 263.27

Quality score

60.25

High Financial Strength

30Day SMA Rs

276.81 Rs

Price above SMA 276.81

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

44.19

Technically Neutral

Price to Book Value

4.00

Above industry median.

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

PE TTM Price to Earnings

25.40

Above industry median.

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

51.70

RSI is mid-range

Net Profit Qtr Cr

3.68 Cr

Above industry median.

Operating Revenues Qtr Cr

35.33 Cr

Below industry median.

MACD

5.19

MACD above Center

Valuation score

16.67

Expensive Valuation

MACD Signal Line

6.50

MACD above Center

FII holding holding %

0.47 %

No change in FII holding

Promoter holding holding %

44.77 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

260.24 Rs

Price above SMA 260.24

Institutions holding holding %

0.47 %

No change in Institutions holding

200Day SMA Rs

299.34 Rs

Price below SMA-200

NSE MEDICAMEQ
0.00
  • 0.00 Close
  • 0.00 Open
  • 0.00 Volume
Today Low/High
Low 0.00
High 0.00
52 Week Low/High
0.00
0.00

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Medicamen Biotech Ltd. 283.55 25.4 346.4 0.35 3.67 18.91 35.33 46.72 3.99
Sun Pharmaceutical Industries Ltd. 493.8 28.29 118477.43 1.16 494.35 30.45 8184.94 14.25 2.64
Dr. Reddy's Laboratories Ltd. 3923.5 33.1 65208.57 0.5 770.6 3.34 4448.89 10.4 4.64
Divi's Laboratories Ltd. 2205 42.52 58531.72 1.45 388.23 1.75 1389.71 9.67 8.41
Cipla Ltd. 642.9 33.5 51833.81 1.08 242.31 2.47 4376.18 -0.64 3.37
Aurobindo Pharma Ltd. 820.45 16.89 48070.16 0.36 868.3 20.44 6158.43 16.36 3.46
Torrent Pharmaceuticals Ltd. 2397.69 39.58 40578.67 1.33 314 134.92 1946 4.84 8.55
Lupin Ltd. 870.8 -144.12 39447.24 0.57 390.3 -144.75 3845.74 -12.73 2.85